MARKET

PTN

PTN

Palatin Tech
NASDAQ
14.02
+0.02
+0.14%
After Hours: 13.59 -0.43 -3.07% 19:56 05/29 EDT
OPEN
14.28
PREV CLOSE
14.00
HIGH
14.51
LOW
14.00
VOLUME
7.84K
TURNOVER
--
52 WEEK HIGH
31.00
52 WEEK LOW
4.505
MARKET CAP
24.95M
P/E (TTM)
-8.2856
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PTN last week (0518-0522)?
Weekly Report · 4d ago
Palatin Technologies Voluntarily Transfers Stock Listing to Nasdaq
TipRanks · 05/18 22:51
Palatin announces approval of its common stock by Nasdaq
TipRanks · 05/18 20:08
Palatin to Begin Trading on Nasdaq Stock Exchange
PR Newswire · 05/18 20:00
Weekly Report: what happened at PTN last week (0511-0515)?
Weekly Report · 05/18 09:47
Palatin price target lowered to $47.50 from $50 at Alliance Global
TipRanks · 05/14 17:24
Palatin Technologies Earnings Call: Partnerships, Progress, Risks
TipRanks · 05/14 00:46
Transcript: Palatin Techs Q3 2026 Earnings Conference Call
Benzinga · 05/13 15:31
More
About PTN
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. The MCR system has effects on inflammation and immune system response, food intake, metabolism, and sexual function. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. Its product development activities focus primarily on the use of MC4R agonists for treatment of obesity. It develops MC4R peptides and small molecule agonists with potential utility in obesity and metabolic-related disorders, rare MC4R pathway diseases, such as hypothalamic obesity, and orphan indications. It also develops MC1R agonist products to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease.

Webull offers Palatin Technologies Inc stock information, including NASDAQ: PTN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTN stock methods without spending real money on the virtual paper trading platform.